Cargando…
Convalescent-anti-SARS-CoV-2-plasma/immunosuppressants: SARS-CoV-2 infection, its re-infection and off label use: case report
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8569091/ http://dx.doi.org/10.1007/s40278-021-04963-z |
Ejemplares similares
-
Anakinra/convalescent-anti-SARS-CoV-2-plasma/prednisolone: Aggravation of SARS-CoV-2 hepatitis, SARS-CoV-2 viraemia and off-label use: case report
Publicado: (2021) -
Convalescent plasma for SARS-CoV-2 infection: win or learn
por: Contreras-Barbeta, Enric, et al.
Publicado: (2022) -
Antibacterials/convalescent-anti-SARS-CoV-2-plasma/immunosuppressants: Cryptococcosis, Staphylococcus aureus infection and lack of efficacy following off-label use: case report
Publicado: (2022) -
Convalescent-anti-SARS-CoV-2-plasma: Lack of efficacy following off-label use: case report
Publicado: (2021) -
Convalescent-anti-SARS-CoV-2-plasma: Transfusion reaction during off-label therapy: case report
Publicado: (2021)